Hikma Pharmaceutical reported $1.41B in Loan Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
AstraZeneca AZN:LN USD 23.68B 3.47B
Bayer BAYN:GR EUR 39.46B 1.4B
Fresenius FRE:GR EUR 25.24B 607M
Fresenius Medical Care FMS:US EUR 12.41B 929.4M
Galapagos GLPG:NA EUR 15.76M 1.12M
Genmab GEN:DC DKK 550M 4M
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Hikma Pharmaceutical HIK:LN USD 1.41B 689M
Lonza Group LONN:SW CHF 1.55B 393M
Merck MRK:GR EUR 9.27B 119M
Orion ORNBV:FH EUR 197.9M 5.4M
Recordati REC:IM EUR 1.4B 46.04M
Roche Holding ROG:VX 22.37B 6.29B